KRAS Therapeutics: Proteomic Assessment of SUMO E2 Ligase as Ant... Although KRAS gene mutations are common in human cancer, the... by Amanda Maxwell / 08.02.2016 Read More KRAS Therapeutics: Proteomic Assessment of SUMO E2 Ligase as Anti-Cancer Target
Pancreatic Cancer Biomarkers: Optimized Detection of Core Fucosy... The research team of Tan et al. recently applied an optimize... by Melissa J. Mayer / 07.27.2015 Read More Pancreatic Cancer Biomarkers: Optimized Detection of Core Fucosylation Sites
Pancreatic Cancer Survival: Proteomics Reveals Prognostic Factor... Recently, Chen et al. (2015) applied label-free proteomics t... by Melissa J. Mayer / 04.10.2015 Read More Pancreatic Cancer Survival: Proteomics Reveals Prognostic Factors and Therapeutic Targets
Pancreatic Cancer Phosphorylome and Potential Drug Networks Phosphorylation, a common post-translational modification (P... by Amanda Maxwell / 11.17.2014 Read More Pancreatic Cancer Phosphorylome and Potential Drug Networks
Tumors in Genetic Flux: Biomarker Discovery for Heterogeneous Pa... One of the key factors contributing to the poor prognosis fo... by Amanda Maxwell / 10.24.2014 Read More Tumors in Genetic Flux: Biomarker Discovery for Heterogeneous Pancreatic Metastases
LC-MS/MS Proteomic Analysis of Banked Pancreatic Tissue Samples Formalin-fixed paraffin-embedded (FFPE) tissue banks are a h... by Amanda Maxwell / 01.08.2014 Read More LC-MS/MS Proteomic Analysis of Banked Pancreatic Tissue Samples
